| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.6 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | -0.074 | 0.6 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.6 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.036 | 0.6 |